Concentrations of IGF-I and IGFBP-3 and pancreatic cancer risk in the European Prospective Investigation into Cancer and Nutrition

British Journal of Cancer

Volumn 106, Issue 5, 2012, Pages 1004-1010

  Rohrmann, S ^a,b   Grote, V A ^b   Becker, S ^b,c   Rinaldi, S ^d   Tjonneland A ^e   Roswall, N ^e   Gronbaek H ^f   Overvad, K ^g   Boutron Ruault, M C ^h,i   Clavel Chapelon, F ^h,i   Racine, A ^h,i   Teucher, B ^b   Boeing, H ^j   Drogan, D ^j   Dilis, V ^k   Lagiou, P ^l,m,n   Trichopoulou, A ^k,l   Palli, D ^o   Tagliabue, G ^p   Tumino, R ^q   Vineis, P ^r,s   Mattiello, A ^t   Rodriguez L ^u   Duell, E J ^v   Molina Montes, E ^w,x   Dorronsoro, M ^y   Huerta, J M ^x,z   Ardanaz, E ^x,aa   Jeurnink, S ^ab,ac   Peeters, P H M ^ac   Lindkvist, B ^ad   Johansen, D ^ae   Sund, M ^af   Ye, W ^af,ag   Khaw, K T ^ah   Wareham, N J ^ai   Allen, N E ^aj   Crowe, F L ^aj   Fedirko, V ^d   Jenab, M ^d   Michaud, D S ^r,ak   Norat, T ^r   Riboli, E ^r   Bueno De Mesquita, H B ^ab,ac   Kaaks, R ^b   more..

^a UNIVERSITY OF ZURICH   (Switzerland)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^d INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^e DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^f AARHUS UNIVERSITY HOSPITAL   (Denmark)

^g AARHUS UNIVERSITY   (Denmark)

^h INSTITUT GUSTAVE ROUSSY   (France)

ⁱ UNIVERSITÉ PARIS SACLAY   (France)

^j GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

^k HELLENIC HEALTH FOUNDATION   (Greece)

^l UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^m BIOMEDICAL RESEARCH FOUNDATION   (Greece)

ⁿ HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^o CANCER RESEARCH AND PREVENTION INSTITUTE ISPO   (Italy)

^p NATIONAL CANCER INSTITUTE   (Italy)

^q CIVILE M P AREZZO HOSPITAL   (Italy)

^r IMPERIAL COLLEGE LONDON   (United Kingdom)

^s HuGeF Foundation   (Italy)

^t UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^u Health and Health Care Services Council   (Spain)

^v CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^w ANDALUSIAN SCHOOL OF PUBLIC HEALTH   (Spain)

^x Consortium for Biomed Research in Epidemiology and Public Health de Epidemiologia y Salud Publica ^*  (Spain)

^y Epidemiology and Health Information   (Spain)

^z Murcia Regional Health Authority   (Spain)

^aa INSTITUTO DE SALUD PÚBLICA DE NAVARRA   (Spain)

^ab NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^ac UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^ad UNIVERSITY OF GOTHENBURG   (Sweden)

^ae LUND UNIVERSITY HOSPITAL   (Sweden)

^af UMEÅ UNIVERSITY   (Sweden)

^ag KAROLINSKA INSTITUTE   (Sweden)

^ah UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^ai MRC EPIDEMIOLOGY UNIT   (United Kingdom)

^aj UNIVERSITY OF OXFORD   (United Kingdom)

^ak BROWN UNIVERSITY   (United States)

more..

Author keywords

cohort study; IGF I; IGFBP 3; pancreatic cancer

Indexed keywords

SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER RISK; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EUROPE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; DIET; EUROPE; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; LIFE STYLE; MALE; MIDDLE AGED; ODDS RATIO; PANCREATIC NEOPLASMS; RISK FACTORS;

EID: 84857787958     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2012.19     Document Type: Article

References (43)

1. Batty GD, Shipley MJ, Marmot M, Smith GD (2004) Diabetes status and post-load plasma glucose concentration in relation to site-specific cancer mortality: findings from the original Whitehall study. Cancer Causes Control 15: 873-881 (Pubitemid 39663863)
2. Bergmann U, Funatomi H, Yokoyama M, Beger HG, Korc M (1995) Insulinlike growth factor I overexpression in human pancreatic cancer: evidence for autocrine and paracrine roles. Cancer Res 55: 2007-2011
3. Berrington de Gonzalez A, Sweetland S, Spencer E (2003) A metaanalysis of obesity and the risk of pancreatic cancer. Br J Cancer 89: 519-523 (Pubitemid 37026437)
4. Chan JM, Stampfer MJ, Giovannucci E, Gann PH, Ma J, Wilkinson P, Hennekens CH, Pollak M (1998) Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study. Science 279: 563-566 (Pubitemid 28067285)
5. Douglas JB, Silverman DT, Pollak MN, Tao Y, Soliman AS, Stolzenberg-Solomon RZ (2010) Serum IGF-I, IGF-II, IGFBP-3, and IGF-I/IGFBP-3 molar ratio and risk of pancreatic cancer in the prostate, lung, colorectal, and ovarian cancer screening trial. Cancer Epidemiol Biomarkers Prev 19: 2298-2306
6. Evans JD, Eggo MC, Donovan IA, Bramhall SR, Neoptolemos JP (1997) Serum levels of insulin-like growth factors (IGF-I and IGF-II) and their binding protein (IGFBP-3) are not elevated in pancreatic cancer. Int J Pancreatol 22: 95-100 (Pubitemid 27500563)
7. Ferlay J, Parkin DM, Steliarova-Foucher E (2010) Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer 46: 765-781
8. Firth SM, Baxter RC (2002) Cellular actions of the insulin-like growth factor binding proteins. Endocr Rev 23: 824-854 (Pubitemid 35454590)
9. Gapstur SM, Gann PH, Lowe W, Liu K, Colangelo L, Dyer A (2000) Abnormal Glucose Metabolism and Pancreatic Cancer Mortality. JAMA 283: 2552-2558 (Pubitemid 30324198)
10. Goodman-Gruen D, Barrett-Connor E (1997) Epidemiology of insulin-like growth factor-I in elderly men and women. The Rancho Bernardo Study. Am J Epidemiol 145: 970-976 (Pubitemid 27215479)
11. Grimberg A, Cohen P (2000) Role of insulin-like growth factors and their binding proteins in growth control and carcinogenesis. J Cell Physiol 183: 1-9 (Pubitemid 30130219)
12. Grote VA, Rohrmann S, Nieters A, Dossus L, Tjonneland A, Halkjaer J, Overvad K, Fagherazzi G, Boutron-Ruault MC,Morois S, Teucher B, Becker S, Sluik D, Boeing H, Trichopoulou A, Lagiou P, Trichopoulos D, Palli D, Pala V, Tumino R, Vineis P, Panico S, Rodriguez L, Duell EJ, Molina-Montes E, Dorronsoro M, Huerta JM, Ardanaz E, Jeurnink SM, Beulens JW, Peeters PH, Sund M, Ye W, Lindkvist B, Johansen D, Khaw KT, Wareham N, Allen N, Crowe F, JenabM, Romieu I, Michaud DS, Riboli E, Romaguera D, Bueno-de-Mesquita HB, Kaaks R (2011) Diabetes mellitus, glycated haemoglobin and C-peptide levels in relation to pancreatic cancer risk: astudy within the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. Diabetologia 54: 3037-3046
13. Haftenberger M, Lahmann PH, Panico S, Gonzalez CA, Seidell JC, Boeing H, Giurdanella MC, Krogh V, Bueno-de-Mesquita HB, Peeters PH, Skeie G, Hjartaker A, Rodriguez M, Quiros JR, Berglund G, Janlert U, Khaw KT, Spencer EA, Overvad K, Tjonneland A, Clavel-Chapelon F, Tehard B, Miller AB, Klipstein-Grobusch K, Benetou V, Kiriazi G, Riboli E, Slimani N (2002) Overweight, obesity and fat distribution in 50-to 64-year-old participants in the European Prospective Investigation into Cancer and Nutrition (EPIC). Public Health Nutr 5: 1147-1162 (Pubitemid 36313610)
14. Huxley R, Ansary-Moghaddam A, Berrington de Gonzalez A, Barzi F, Woodward M (2005) Type-II diabetes and pancreatic cancer: a metaanalysis of 36 studies. Br J Cancer 92: 2076-2083 (Pubitemid 40897433)
15. Jee SH, Ohrr H, Sull JW, Yun JE, Ji M, Samet JM (2005) Fasting serum glucose level and cancer risk in Korean men and women. JAMA 293: 194-202 (Pubitemid 40095870)
16. Jiao L, Berrington de Gonzalez A, Hartge P, Pfeiffer R, Park Y, Freedman D, Gail M, Alavanja M, Albanes D, Beane Freeman L, Chow W-H, Huang W-Y, Hayes R, Hoppin J, Ji B-t, Leitzmann M, Linet M, Meinhold C, Schairer C, Schatzkin A, Virtamo J, Weinstein S, Zheng W, Stolzenberg-Solomon R (2010) Body mass index, effect modifiers, and risk of pancreatic cancer: a pooled study of seven prospective cohorts. Cancer Causes Control 21: 1305-1314
17. Jones JI, Clemmons DR (1995) Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev 16: 3-34
18. Kaaks R, Lukanova A (2001) Energy balance and cancer: the role of insulin and insulin-like growth factor-I. Proc Nutr Soc 60: 91-106 (Pubitemid 32183103)
19. Kaaks R, Rinaldi S, Lukanova A, Akhmedkhanov A, Zeleniuch-Jacquotte A, Toniolo P (2001) Correspondence re: Giovannucci et al., A prospective study of plasma insulin-like growth factor-1 and binding protein-3 and risk of colorectal neoplasia in women. Cancer Epidemiol Biomark Prev 9: 345-349.
20. 2000; Cancer Epidemiol Biomark Prev 10: 1103-1104
21. Kaaks R, Slimani N, Riboli E (1997) Pilot phase studies on the accuracy of dietary intake measurements in the EPIC project: overall evaluation of results. European Prospective Investigation into Cancer and Nutrition. Int J Epidemiol 26(Suppl 1): S26-S36 (Pubitemid 27129687)
22. Karna E, Surazynski A, Orlowski K, Laszkiewicz J, Puchalski Z, Nawrat P, Palka J (2002) Serum and tissue level of insulin-like growth factor-I (IGF-I) and IGF-I binding proteins as an index of pancreatitis and pancreatic cancer. Int J Exp Pathol 83: 239-246
23. Khandwala HM, McCutcheon IE, Flyvbjerg A, Friend KE (2000) The effects of insulin-like growth factors on tumorigenesis and neoplastic growth. Endocr Rev 21: 215-244 (Pubitemid 32275588)
24. Lee PD, Giudice LC, Conover CA, Powell DR (1997) Insulin-like growth factor binding protein-1: recent findings and new directions. Proc Soc Exp Biol Med 216: 319-357
25. Lin Y, Tamakoshi A, Kikuchi S, Yagyu K, Obata Y, Ishibashi T, Kawamura T, Inaba Y, Kurosawa M, Motohashi Y, Ohno Y (2004) Serum insulin-like growth factor-I, insulin-like growth factor binding protein-3, and the risk of pancreatic cancer death. Int J Cancer 110: 584-588 (Pubitemid 38658024)
26. Lowenfels AB, Maisonneuve P (2004) Epidemiology and Prevention of Pancreatic Cancer. Jpn J Clin Oncol 34: 238-244 (Pubitemid 43102883)
27. Lukanova A, Zeleniuch-Jacquotte A, Lundin E, Micheli A, Arslan AA, Rinaldi S, Muti P, Lenner P, Koenig KL, Biessy C, Krogh V, Riboli E, Shore RE, Stattin P, Berrino F, Hallmans G, Toniolo P, Kaaks R (2004) Prediagnostic levels of C-peptide, IGF-I, IGFBP-1,-2 and-3 and risk of endometrial cancer. Int J Cancer 108: 262-268 (Pubitemid 37541781)
28. Ma J, Sawai H, Matsuo Y, Ochi N, Yasuda A, Takahashi H, Wakasugi T, Funahashi H, Sato M, Takeyama H (2010) IGF-1 Mediates PTEN Suppression and Enhances Cell Invasion and Proliferation via Activation of the IGF-1/PI3K/Akt Signaling Pathway in Pancreatic Cancer Cells. J Surg Res 160: 90-101
29. Nunn SE, Gibson TB, Rajah R, Cohen P (1997) Regulation of prostate cell growth by the insulin-like growth factor binding proteins and their proteases. Endocrine 7: 115-118 (Pubitemid 127483100)
30. Ohmura E, Okada M, Onoda N, Kamiya Y, Murakami H, Tsushima T, Shizume K (1990) Insulin-like growth factor I and transforming growth factor I± as autocrine growth factors in human pancreatic cancer cell growth. Cancer Res 50: 103-107 (Pubitemid 20030002)
31. Pollak MN, Schernhammer ES, Hankinson SE (2004) Insulin-like growth factors and neoplasia. Nat Rev Cancer 4: 505-518 (Pubitemid 38868620)
32. Rajah R, Lee KW, Cohen P (2002) Insulin-like growth factor binding protein-3 mediates tumor necrosis factor-alpha-induced apoptosis: role of Bcl-2 phosphorylation. Cell Growth Differ 13: 163-171 (Pubitemid 34507095)
33. Rajah R, Valentinis B, Cohen P (1997) Insulin-like growth factor (IGF)-binding protein-3 induces apoptosis and mediates the effects of transforming growth factor-beta1 on programmed cell death through a p53-and IGF-independent mechanism. J Biol Chem 272: 12181-12188 (Pubitemid 27202802)
34. Renehan AG, Zwahlen M, Minder C, O'Dwyer ST, Shalet SM, Egger M (2004) Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. Lancet 363: 1346-1353 (Pubitemid 38529873)
35. Riboli E, Kaaks R (1997) The EPIC Project: rationale and study design. European Prospective Investigation into Cancer and Nutrition. Int J Epidemiol 26(Suppl 1): S6-S14
36. Rinaldi S, Cleveland R, Norat T, Biessy C, Rohrmann S, Linseisen J, Boeing H, Pischon T, Panico S, Agnoli C, Palli D, Tumino R, Vineis P, Peeters PH, van Gils CH, Bueno-de-Mesquita BH, Vrieling A, Allen NE, Roddam A, Bingham S, Khaw KT, Manjer J, Borgquist S, Dumeaux V, Torhild Gram I, Lund E, Trichopoulou A, Makrygiannis G, Benetou V, Molina E, Donate Suarez I, Barricarte Gurrea A, Gonzalez CA, Tormo MJ, Altzibar JM, Olsen A, Tjonneland A, Gronbaek H, Overvad K, Clavel-Chapelon F, Boutron-Ruault MC, Morois S, Slimani N, Boffetta P, Jenab M, Riboli E, Kaaks R (2010) Serum levels of IGF-I, IGFBP-3 and colorectal cancer risk: results from the EPIC cohort, plus a meta-analysis of prospective studies. Int J Cancer 126: 1702-1715
37. Rinaldi S, Kaaks R, Zeleniuch-Jacquotte A, Arslan AA, Shore RE, Koenig KL, Dossus L, Riboli E, Stattin P, Lukanova A, Toniolo P (2005) Insulinlike growth factor-I, IGF binding protein-3, and breast cancer in young women: a comparison of risk estimates using different peptide assays. Cancer Epidemiol Biomarkers Prev 14: 48-52 (Pubitemid 40165282)
38. Roddam AW, Allen NE, Appleby P, Key TJ, Ferrucci L, Carter HB, Metter EJ, Chen C, Weiss NS, Fitzpatrick A, Hsing AW, Lacey Jr JV., Helzlsouer K, Rinaldi S, Riboli E, Kaaks R, Janssen JA, Wildhagen MF, Schroder FH, Platz EA, Pollak M, Giovannucci E, Schaefer C, Quesenberry Jr CP, Vogelman JH, Severi G, English DR, Giles GG, Stattin P, Hallmans G, Johansson M, Chan JM, Gann P, Oliver SE, Holly JM, Donovan J, Meyer F, Bairati I, Galan P (2008) Insulin-like growth factors, their binding proteins, and prostate cancer risk: analysis of individual patient data from 12 prospective studies. Ann Intern Med 149: 461-471, W83-W88
39. Stattin P, Björ O, Ferrari P, Lukanova A, Lenner P, Lindahl B, Hallmans G, Kaaks R (2007) Prospective study on hyperglycemia and cancer risk. Diabetes Care 30: 561-567 (Pubitemid 46354334)
40. Stolzenberg-Solomon RZ, Graubard BI, Chari S, Limburg P, Taylor PR, Virtamo J, Albanes D (2005) Insulin, Glucose, Insulin Resistance, and Pancreatic Cancer in Male Smokers. JAMA 294: 2872-2878 (Pubitemid 41785868)
41. Stolzenberg-Solomon RZ, Limburg P, Pollak M, Taylor PR, Virtamo J, Albanes D (2004) Insulin-like growth factor (IGF)-1, IGF-binding protein-3, and pancreatic cancer in male smokers. Cancer Epidemiol Biomarkers Prev 13: 438-444 (Pubitemid 38737470)
42. The Endogenous Hormones and Breast Cancer Collaborative Group (2010) Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studies. Lancet Oncol 11: 530-542
43. Wolpin BM, Michaud DS, Giovannucci EL, Schernhammer ES, Stampfer MJ, Manson JE, Cochrane BB, Rohan TE, Ma J, Pollak MN, Fuchs CS (2007) Circulating insulin-like growth factor axis and the risk of pancreatic cancer in four prospective cohorts. Br J Cancer 97: 98-104 (Pubitemid 47012086)